Literature DB >> 34029488

Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.

Caoilfhionn M Connolly1, Brian J Boyarsky1, Jake A Ruddy1, William A Werbel1, Lisa Christopher-Stine1, Jacqueline M Garonzik-Wang1, Dorry L Segev1, Julie J Paik1.   

Abstract

Entities:  

Year:  2021        PMID： 34029488     DOI： 10.7326/M21-1451

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  14 in total

1.  Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease.

Authors:  Giacomo Malipiero; Anna Moratto; Maria Infantino; Pierlanfranco D'Agaro; Elisa Piscianz; Mariangela Manfredi; Valentina Grossi; Enrico Benvenuti; Matteo Bulgaresi; Maurizio Benucci; Danilo Villalta
Journal:  Immunol Res       Date:  2021-08-21       Impact factor: 4.505

2.  High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.

Authors:  Jake A Ruddy; Caoilfhionn Marie Connolly; Brian J Boyarsky; William A Werbel; Lisa Christopher-Stine; Jacqueline Garonzik-Wang; Dorry L Segev; Julie J Paik
Journal:  Ann Rheum Dis       Date:  2021-05-24       Impact factor: 19.103

3.  Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study.

Authors:  Satveer K Mahil; Katie Bechman; Antony Raharja; Clara Domingo-Vila; David Baudry; Matthew A Brown; Andrew P Cope; Tejus Dasandi; Carl Graham; Hataf Khan; Thomas Lechmere; Michael H Malim; Freya Meynell; Emily Pollock; Kamila Sychowska; Jonathan N Barker; Sam Norton; James B Galloway; Katie J Doores; Timothy Tree; Catherine H Smith
Journal:  Lancet Rheumatol       Date:  2021-11-09

4.  Mandating COVID-19 vaccination prior to kidney transplantation in the United States: No solutions, only decisions.

Authors:  Benjamin E Hippen
Journal:  Am J Transplant       Date:  2021-11-24       Impact factor: 9.369

5.  Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal.

Authors:  Caoilfhionn M Connolly; Julie J Paik
Journal:  Lancet Rheumatol       Date:  2022-03-17

6.  Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort.

Authors:  May Y Choi; Ann Elaine Clarke; Katherine Buhler; Michelle Jung; Hannah Mathew; Meifeng Zhang; Francesca S Cardwell; Heather Waldhauser; Marvin J Fritzler
Journal:  Lupus Sci Med       Date:  2022-04

Review 7.  COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations.

Authors:  Rebecca Grainger; Alfred H J Kim; Richard Conway; Jinoos Yazdany; Philip C Robinson
Journal:  Nat Rev Rheumatol       Date:  2022-02-25       Impact factor: 32.286

8.  Inter-individual variation in objective measure of reactogenicity following COVID-19 vaccination via smartwatches and fitness bands.

Authors:  Giorgio Quer; Matteo Gadaleta; Jennifer M Radin; Kristian G Andersen; Katie Baca-Motes; Edward Ramos; Eric J Topol; Steven R Steinhubl
Journal:  NPJ Digit Med       Date:  2022-04-19

Review 9.  Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy.

Authors:  Nina M Bemben; Melody L Berg
Journal:  Pharmacotherapy       Date:  2022-02-18       Impact factor: 6.251

10.  SARS-CoV-2 seroprevalence, seroconversion and neutralizing antibodies in a systemic lupus erythematosus cohort and comparison to controls.

Authors:  Hannah R Mathew; May Y Choi; Katherine Buhler; Xenia Gukova; Francesca S Cardwell; Heather Waldhauser; Ann E Clarke; Marvin J Fritzler
Journal:  Lupus       Date:  2021-12-07       Impact factor: 2.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.